Platelet-derived growth factor (PDGF) is one of several known growth factors involved in the regulation of cell proliferation (see reference 37 for references). This growth factor consists of two related chains, the products of different genes, PDGF-1 and PDGF-2. The PDGF-2 gene, the human homolog to the v-sis oncogene, confers the transformed phenotype to NIH 3T3 cells if expressed under the control of a strong eucaryotic promoter (14) . PDGF-2 mRNA can normally be found in endothelial cells (5) and placental trophoblasts (17) . While normal fibroblasts and glial cells do not contain detectable levels of this transcript, a large fraction of sarcoma and glioblastoma cell lines or tumor tissues express the 3.7-kilobase (kb) mRNA (13) . Since fibroblasts and glial cells possess PDGF receptors and can be stimulated by PDGF (7, 19) , expression of this growth factor may be important in the generation of such human malignancies. A prerequisite for understanding how PDGF-2 expression is activated in these tumors is a knowledge of the control mechanisms involved.
A system in which PDGF-2 expression can be induced makes it possible to dissect different regulatory mechanisms and determine their contribution during induction. PDGF-2 mRNA is induced in HL-60 and U-937 cells during differentiation along the monocytic-macrophage lineage (31) , in activated human monocytes (28) , and in mouse embryoderived AKR-2B cells treated with transforming growth factor ,3 (25) . When the human hematopoietic stem cell line K562 is induced to differentiate into megakaryoblasts by treatment with phorbol esters, there is a concomitant appearance of PDGF-2 mRNA (3, 10) . We decided to investigate PDGF-2 mRNA induction and promoter activation in sequences between the internal PDGF-2 BglII site and the BamHI site in the polylinker of pGEM4. The human ,-actin template consists of a Sall-XhoII fragment isolated from the 5' portion of a human P-actin cDNA clone (33) inserted into pGEM1. PSV2Cat (16) was a gift from B. Howard, National Cancer Institute (NCI). The P-ActinCat plasmid contains the chicken promoter for 1-actin (23) in an XhoI-HincII fragment which replaces the simian virus 40 promoter in pSV2Cat. It was constructed and kindly provided by B. Paterson, NCI. The eucaryotic expression vector for 1- galactosidase, pCH110, was purchased from Pharmacia Inc., Piscataway, N.J.
Deletion mutagenesis. pSRMCatPAF.M was linearized with BstEII, incubated with exonuclease III (Bethesda Research Laboratories, Gaithersburg, Md.) at 135 U/pmol of 3' ends in 66 mM Tris hydrochloride (pH 8.0)-S5 mM MgCl2 at 15°C. Samples were removed after 1 to 20 min at 1-min intervals, heat inactivated, treated with exonuclease VII, ethanol precipitated, incubated with the Klenow fragment of DNA polymerase I, and ligated with T4 DNA ligase. Plasmid 15/2-1 was generated from BstEII-linearized pSRMCat PAF.M by using nuclease Bal 31. All deletions were analyzed by sequencing.
Site-directed mutagenesis. Site-directed deletions were introduced into pSRMCatPAF.M with the help of 30-mer oligonucleotides spanning the desired deletion. For this purpose, an EcoRI fragment of pSRMCatPAF.M containing the promoter region was first subcloned into M13mp9. An oligonucleotide-directed in vitro mutagenesis system (Amersham, Amersham, United Kingdom), which is based on the Eckstein method (30) , was used to introduce deletions into the M13mp9 inserts, which were then recloned into pSRMCatPAF.M. The deletions were analyzed by sequencing the M13mp9 inserts as well as the respective regions in the final plasmid constructs.
Oligonucleotide synthesis. Oligonucleotides for in vitro mutagenesis, primer extension analysis, sequencing, and gel retardation experiments were synthesized on a Beckman System lPlus DNA Synthesizer.
Sequencing. Sequencing was done by dideoxy chain termination methods (38) . Electroporation and preparation of cell extracts. All DNAs used for electroporation were CsCl gradient-purified, phenol-extracted plasmid DNAs which were suspended in sterile phosphate-buffered saline. Concentrations of closed circular plasmid DNAs were determined by measurement of optical densities as well as by gel electrophoresis prior to electroporation. From 2 x 107 to 4 x 107 cells were washed twice in sterile phosphate-buffered saline and suspended in a volume of 300 Rl in 1.0-ml disposable cuvettes lined with aluminum foil. The cell suspensions were kept on ice, and a mixture of 20 ,ug of pCH110 plasmid DNA with 20 ,ug of test plasmid DNA was added in 100 ,u1 of phosphate-buffered saline. Electroporations were performed at room temperature with a single electrical pulse delivered from a 494 Isco power supply at a voltage of 2 kV (K562 cells) or 1.3 kV (all other cells), limiting the current and wattage to 9 ,uA and 15 mW, respectively. The cells were incubated at 0°C for 15 min, resuspended in culture medium, and plated into a 175-cm2 flask. For induction, the culture was divided after a 12-h incubation into two identical portions, one receiving culture medium supplemented with the appropriate amount of TPA and the other receiving medium only. The cells were harvested after 24 h. Extracts were prepared by the method of Gorman et al. (16) , using three freeze-thaw cycles for cell lysis.
CAT and ,I-galactosidase assays. The amount of 13-galactosidase encoded by pCH110 was used to standardize individual extracts in each electroporation experiment. The assay for 1-galactosidase was performed according to Edlund et al. (12) . Cell extract (20 ,u!) was incubated with and without o-nitrophenyl-13-D-galactoside (Boehringer, Mannheim, Federal Republic of Germany) for the time needed to achieve a visible conversion to the yellow chromogen; the difference in absorbance at 420 nm was used to calculate the specific activity for each extract. This activity determined the correct amount of extract to be used in the chloramphenicol acetyltransferase (CAT) assay, which was performed according to Gorman et al. (16) . Standardization was restricted to each particular cell type and electroporation experiment (separately for induced and uninduced cells). To be able to compare CAT conversion values (percent conversion of chloramphenicol to its acetylated forms) between several independent experiments, we converted these values to relative CAT activity units by defining the percent conversion achieved after electroporation of pSRMCatPAF.M into uninduced K562 cells as 1 U.
Primer extension. After electroporation with CAT plasmids, K562 cell suspensions were divided into two portions. One was used to prepare extracts for CAT and f-galactosidase assays, and the other was used to prepare RNA according to the method of Chirgwin et al. (4) . Different amounts of RNA were hybridized to a 19-bp oligonucleotide primer specific for the 5' end of the cat gene. The primer was end labeled by phosphorylation with polynucleotide kinase and [y-32P]ATP. Labeling and primer extension were performed as described by Geliebter et al. (15) . Extension products were resolved on 8.3 M urea-8% acrylamide sequencing gels alongside sequencing reactions of pSRM CatPAF.M performed with the same primer.
RNase protection assays and RNA quantification. RNase protection assays were done according to Melton et al. (29) under conditions recommended by the commercial supplier of the SP6 and T7 polymerases (Promega Biotec). The following modifications were introduced. Riboprobes were synthesized at 40°C for 1 h; the concentration of UTP in the reaction mixture was 25 ,uM at a specific activity of 230 Ci/mmol. If SP6 polymerase was used, 10 U of enzyme was added a second time after 30 min of incubation. Specific activities and concentrations of riboprobes were calculated based on 32p incorporation. The full-length probes were purified on 8.3 M urea-5% acrylamide sequencing gels and eluted in 1 M NaCl. For hybridizations, 106 cpm of probe and 0.1 to 200 p.g of total RNA were incubated at 50°C in hybridization buffer containing 80% formamide for at least 12 h. RNase digestion was performed at 37°C with 8 U of RNase A and 1,400 U of RNase T1 per ml for 1 h. The protected RNA fragments were resolved on 20-cm-long 8.3 M urea-5% polyacrylamide sequencing gels alongside different amounts of untreated riboprobe. The gels were dried and autoradiographed for various amounts of time ranging from 2 to 5,760 min. Autoradiograms were scanned in a Bio-Rad model 620 videodensitometer, and RNA concentrations were calculated by comparing signal intensities with those generated by different amounts of the corresponding untreated riboprobe. By using different quantities of cellular RNA, it was verified that the hybridization time and amount of probe were sufficient to recover RNA transcripts in hybrids quantitatively.
Gel mobility shift assays. Nuclear extracts of K562 cells were prepared according to Dignam et al. (11) . Gel mobility shift experiments were performed according to Schneider et VOL. 9, 1989 398 PECH ET AL. (10) . In an effort to quantitate low amounts of PDGF-2 transcripts during the early time course of K562 differentiation, we used the sensitive RNase protection assay. No PDGF-2 mRNA was detectable in uninduced K562 cells even when 200 ,ug of total RNA was used. Thus, uninduced K562 cells contained less than 1 PDGF-2 mRNA molecule per ng of total cellular RNA. As shown in Fig. 1 , PDGF-2 mRNA levels increased more than 200-fold within 24 h following TPA exposure. The 0-actin mRNA levels remained unchanged at this TPA concentration. The stimulatory effect of phorbol esters on the activity of some promoters has been shown to be independent of de novo protein synthesis (21) . However, when CHX (40 ,ug/ml) was added at the time of TPA treatment, TPA-mediated induction of PDGF-2 mRNA was completely inhibited (Fig. 1) . ,-Actin mRNA levels in- creased about twofold under these cc sults were obtained with CHX at 10 ,ug It has been demonstrated for a r mRNAs that inhibition of protein sy mRNA levels (18) , suggesting that a la involved in regulating expression of tl When we first induced K562 cells for 24 added CHX (10 or 40 ,Lg/ml), we observ of PDGF-2 mRNA (Fig. 2) . In additio cells with CHX alone did not result in mRNA (Fig. 2) In contrast, PDGF-2 promoter activity in K562 cells bile protein might be induced to differentiate into megakaryoblasts varied over hese transcripts (22) . more than a 20-fold range depending on the deletion mutant h with TPA and then (Fig. 4) ed by a labile protein. 4). In Ex 14-3 and Ex 13-3, the 3' deletion endpoints were gulation in differentiidentical. However, juxtaposition of a sequence located te the contribution of between 1 and 61 bp downstream of the EcoRI site to the In of PDGF-2 mRNA positive regulatory region (see below) in Ex 13-3 completely illy characterize the abolished inducibility. Thus, analysis of these and the other ie used two plasmids, deletion mutants led to the tentative localization of a trantMCatPAF.M, which scriptional silencer (-symbol in Fig. 4 ) within a stretch of 30 iter region (36 high levels of induction in the absence of the silencer element. Induced activity declined more than fivefold when the deletions included sequences from 301 to 306 bp downstream of the EcoRI site (Ex 14-2 to 15-2/1, 73 to 68 bp upstream of the TATA box; Fig. 4 and 5 ) and dropped to background levels when the deletions extended to position 345 (Ex 17-1, Fig. 4 and 5) . Thus, by deletion mapping we were able to localize a positive regulatory region (+ symbol in Fig. 4 or Bal31 (mutant 15/2-1) were electroporated together with pCH110 DNA into K562 cells. Cultures were split into two portions, one of which was treated with TPA. The amount of extracts used for determination of CAT activity was standardized by measuring 3-galactosidase activity (see Materials and Methods). Calculations of CAT activities for each deletion mutant were based on the activity determined after electroporation of pSRMCatPAF.M into uninduced K562 cells. Thus, the CAT activity of pSRMCatPAF.M in uninduced K562 cells was defined as 1 U. CAT activities of deletion mutants which were tested in more than two independent experiments are shown with their standard errors. Ex 14-2 and Ex 15-2 were tested in seven independent experiments for their activity in uninduced K562 cells and in four independent experiments in TPA-induced cells. The induced activity of Ex 14-2 (24.8 + 6.9 U) is at a probability level of P < 0.01 (Student's t test) larger than the induced activity of Ex 15-2 (1.8 t 0.4 U), whereas the difference in uninduced activities is not statistically significant (P = 0.05). The EcoRI-Fspl restriction fragment including the Spl-binding sites, TATA signal sequence, and cap site within the parental plasmid is represented by a solid bar. The extent of the deletion within different mutants is indicated by the size of the gap. Ex 0-1 is identical in its sequence to the parent plasmid. PSV2Cat was strongly induced by TPA, whereas ,B-ActinCat showed identical activities in induced and uninduced cells. Regions defined by deletion analysis to exert a positive (+) or negative (-) effect on induced PDGF-2 promoter activity are demarcated by vertical lines. Deletion of only one of two hypothetical Spl-binding sites also decreased induced promoter activity. The scale refers to fragment length in nucleotides.
Recent studies have identified a consensus sequence that is the target for activation protein 1 (AP-1), seems to regulate the activities of certain promoters in cells treated with phorbol esters (4, 24) . We found a sequence homologous to this consensus sequence, TGAGTCAG (4) or TGACTCA (24) , within the positive regulatory region. It was located 62 to 55 bp upstream of the TATA box (sequence TGACTCCG at positions 312 to 319, Fig. 5 ). Deletion of this region, however, did not change the promoter activity in uninduced or TPA-induced K562 cells (5S in Fig. 5) . Thus (Fig. 6A) . Lowering the poly(dI-dC) poly(dI-dC) concentration unmasked two other specific oligonucleotide-nuclear protein interactions which could be detected at lower polyacrylamide concentrations (Fig. 6B) . The specificity of these interactions was confirmed by competition experiments (Fig. 6B) . The abundance of these two complexes did not seem to change after TPA induction. Thus, interaction of the PDGF-2 upstream promoter region with nuclear factors from K562 cells could generate three different complexes, one of which was more abundant after TPA-mediated differentiation. That CAT activities of PDGF-2 promoter mutants generated by site-directed mutagenesis. Electroporation and determination of PDGF-2 promoter activities were performed as described in the legend to Fig. 4 and Materials and Methods. Deletions generated by site-directed mutagenesis are indicated by horizontal bars below a section of the PDGF-2 promoter sequence. The 3' deletion endpoints of some of the mutants shown in Fig. 4 are also illustrated. Sequences homologous to the binding sites for the transcriptional factor Spl (SP1) or AP-1 (TRE) are boxed. Nucleotide positions are given relative to the EcoRl site. different nuclear proteins can bind to one short promoter element is well documented (39) .
Role of the positive regulatory region in PDGF-2 promoter expression in normal and tumor cells. We wanted to investigate the possiblity that the presence of PDGF-2 mRNA in some human tumor cells might be due to transcriptional activation involving the identified upstream promoter region. Thus, deletion mutants Ex 14-2 and Ex 15-2 ( Fig. 4 and 5) were introduced by electroporation into normal fibroblasts (M413 cells) and four different human tumor cell lines which have been shown to express different levels of PDGF-2 mRNA (13, 20) . As shown in Table 1 , deletion of the sequence between 73 and 42 bp upstream of the TATA box had nearly identical effects on PDGF-2 promoter activity in human fibroblasts as well as in the glioblastoma and fibrosarcoma cell lines independent of whether they expressed PDGF-2 mRNA. In one line, the EJ bladder carcinoma cell line, there was a significantly reduced level of promoter activity associated with the construct in which the positive regulatory region had been deleted. Thus, the higher level of PDGF mRNA in EJ cells (20) appears to correlate with the ability of EJ cells to trans-activate the target sequences between 73 and 42 bp upstream of the TATA signal in the PDGF-2 promoter.
DISCUSSION
PDGF-2 expression appears to be tightly controlled, since only a few differentiated tissues normally express its transcript (37) . In fact, there is accumulating evidence that expression of PDGF-2 in cells possessing the cognate receptor may play a role in the development of certain malignancies (35) . Our present report describes the initial functional analysis of the PDGF-2 promoter region. For these studies, we used the K562 cell line, which differentiates along the megakaryocyte pathway following TPA treatment associated with activation of PDGF-2 mRNA expression (3, 10) . Our studies defined the early kinetics of induction in which, over a 24-h period, the levels of PDGF-2 mRNA increased more than 200-fold above an undetectable level of less than 1 molecule per ng of total cellular RNA.
Using deletion mutagenesis and the cat reporter gene, we identified a minimum region of 42 bp upstream of the TATA box which was required for promoter activity in uninduced cells (Fig. 7) . In addition, two upstream regions which affected TPA inducibility were identified by deletion analysis. A transcriptional silencer exerted a negative effect on TPA inducibility; a positive regulatory region was also 'A 24 identified (Fig. 7) .
The silencer was further shown to exert its inhibitory ' X effect when fused to sequences within the positive regulatory 2 2 region. This silencer contains part of the sequence CTG AGTCCC which was homologous to the sequence CTGA CTCCG located within the positive regulatory region. This raises the possiblity that homologous sequences may be targets for identical or related transcriptional factors exertw^i ng positive as well as negative effects on promoter activity.
The consensus sequence for the target of the transcriptional factor AP-1 is TGAGTCAG or TGACTCA (4, 24 66 octamer TGACTCCG had no effect on promoter activity and extending the 5' deletions from position 301 to 306 (Fig. 4 and 5) led to a significant decline in inducibility, one target r-i -N element for trans-activation or an essential part of it is likely + + + + to be contained within the sequence CCTCCTGGCGC between positions 301 and 311 (sequence 1, Fig. 7 ). This element was part of oligonucleotide 13, used in the gel retardation assays. The sequence is located at the beginning of a stretch of 100 bp encompassing the TATA signal sequence and the cap site. This stretch shows 98% sequence identity with the 5' sequence of the feline c-sis/PDGF-2 proto-oncogene (42) , which points to its functional significance. While deletion of the positive regulatory region /** reduced the TPA inducibility of the reporter gene about eightfold when comparing mutant Ex 14-2 with Ex 15-2, it led to only a threefold reduction when comparing mutant A4 J with A3. The latter were generated by site-directed mutagenesis, whereas the former had all the other upstream sequences deleted as well. Thus, the absence of the silencer region is likely to increase the effect of deleting the positive promoter eleregulatory element. Deletion of another 13 bp downstream Is described in (sequence 2, Fig. 7 ) reduced induced and uninduced properiments. (A) moter activity to nearly background levels. Thus, sequences retardation of essential for PDGF-2 promoter activity must be located 344, Fig. 5 transcripts was demonstrated in primer extension assays. Although it is difficult to compare directly promoter activities based on CAT assays with endogenous mRNA levels, the differences observed were large enough that it seems very likely that the PDGF-2 promoter is constitutively active in uninduced K562 cells. Thus, other levels of regulation must exist. The PDGF-2 transcript might be either terminated prematurely, as has been demonstrated for c-myc mRNA expression (6), or degraded very rapidly. If premRNA degradation were to constitute a second level of regulation, it is unlikely to be controlled by a labile protein in K562 cells, since the PDGF-2 transcript could not be superinduced by CHX. Nuclear runoff experiments with K562 nuclei should help to differentiate between these possibilities.
There is evidence of dysregulation of PDGF-2 RNA expression in a majority of human fibrosarcomas and glioblastomas (13, 20) . Measurement of PDGF-2 transcripts in normal human fibroblasts indicates levels at least 200-to 1,000-fold lower than observed in TPA-induced K562 cells or under steady-state conditions in normal human endothelial cells and some human glioblastomas and fibrosarcomas (M. Pech, unpublished). Yet human fibroblasts as well as uninduced K562 cells expressed the cat reporter gene driven by the minimal PDGF-2 promoter. In one of several tumor cell lines examined, the positive regulatory region identified by us conferred a significant enhancement in reporter gene activity, consistent with the fact that this cell line constitutively expresses high levels of PDGF-2 mRNA. These findings support the concept that alterations in tumor cells can enhance PDGF-2 expression by means of trans-acting factors that interact with this element. However, our findings strongly argue that PDGF-2 gene expression in fibroblasts and uninduced K562 cells is also regulated beyond promoter control. Evaluation of this level of control will be critical in determining the mechanism which causes PDGF-2 mRNA to be expressed under most conditions in human malignancies.
